̽»¨Ö±²¥

̽»¨Ö±²¥stirrings of a revolution are starting to ripple through hundreds of laboratories. It’s a revolution that aims to result in new medicines –...

Cambridge-based start-up company Bicycle Therapeutics has recently raised £40 million from a range of investors to bring its cancer drug candidates...

When you’re under attack, you fight back. You gather your troops and attack the invading enemy, hoping to wound and defeat them, while supporting and...

An approved anti-cancer drug successfully targets the first step in the toxic chain reaction that leads to Alzheimer’s disease, suggesting that...

An innovative new Consortium will act as a ‘match-making’ service between pharmaceutical companies and researchers in Cambridge with the aim of...

Alzheimer’s Research UK, the world’s largest dedicated dementia research charity, has announced a £30 million Drug Discovery Alliance, launching...

New study describes a fundamental mechanism regulating a protein’s shape and function, with potential applications in biotechnology and drug...

A combination of nanotechnology and a unique twisting property of light could lead to new methods for ensuring the purity and safety of...